What are the surgical treatments for lung cancer? What are the common surgical treatments for lung cancer?

The treatment of almost all malignant tumors is based on comprehensive treatment, and the same is true for the treatment of lung cancer. However, since lung cancer is a very complex disease, the treatment of lung cancer should not only be cautious, but also determine the appropriate treatment plan based on the different characteristics of the disease. The following is an introduction to the common surgical treatment of lung cancer:

① For peripheral lung cancer (including small cell lung cancer that was not diagnosed before surgery), surgery is performed first, and then chemotherapy or radiotherapy is given according to the results of pathological examination.

② For lung cancer with local lymph node metastasis but no clear distant metastasis, preoperative chemotherapy or radiotherapy is given to ensure a smooth operation and to preserve healthy lung tissue to the maximum extent possible, and then appropriate chemotherapy or radiotherapy is given afterwards.

③ For lung cancer with no distant metastasis but estimated to be difficult to undergo radical surgery, preoperative chemotherapy or radiotherapy should be given to ensure smooth radical surgery or intraoperative radiotherapy. Postoperative chemotherapy or radiotherapy should be given again based on the results of pathological examination.

④ For those in the more advanced stages who cannot undergo surgical treatment, radiotherapy is usually performed first and then chemotherapy, or chemotherapy and radiotherapy are performed simultaneously to achieve a synergistic effect. However, chemotherapy and radiotherapy have significant side effects, so they should be used in conjunction with traditional Chinese medicine to reduce toxic side effects and improve efficacy. Immunotherapy can also be appropriately added to promote recovery.

⑤ Combining biological therapy with other treatments. Biological therapy is a relatively new therapy that has emerged in the past 10 years. For example, colony stimulating factor can appropriately increase the chemotherapy dose to improve the efficacy. Daily intrapleural injection of small doses of interleukin-2 is conducive to the conversion of cancer cells in postoperative cancerous pleural effusion to negative.

The success rate of early surgical resection of lung cancer is certain, but because the early symptoms of lung cancer are not obvious, they are very easy to be ignored by patients. In this case, people are required to understand this highly prevalent malignant tumor, especially how to reduce the incidence rate and the symptoms.